Type 2 Diabetes Trial, Not Yet Recruiting NCT07396402 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07396402
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women between the ages of 18 and 35 years old
  • People who have been diagnosed with polycystic ovary syndrome (PCOS), either the type that affects insulin levels or the type that does not
  • People who have results available from baseline hormone blood tests and a sugar-processing test (called an oral glucose tolerance test)
  • Healthy women without PCOS (for the comparison group in the trial)
  • People who are willing and able to give written consent to participate

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently pregnant
  • People who have a history of heart or blood vessel disease
  • People who have diabetes or have been told their body does not process sugar normally
  • People who have high blood pressure
  • People who have serious liver or kidney disease
  • People who have other hormone-related conditions (confirm with trial site)
  • People who have or have had cancer or tumour-related diseases
  • People who have a psychiatric disorder
  • People who have an autoimmune disease
  • People who work shift work (such as rotating or night shifts)
  • People who are living with obesity
  • People who are not willing to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rosanna Apa, MD, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630155872

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
1 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Circulating SCUBE-1 levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov